Table 4.

Liver biopsy findings in the sample

Liver parameters (n = 30)
NAS (0–8)	Non-NASH (NAS 0–2)	Borderline NASH (NAS 3–4)	NASH (NAS 5–8)
	20%; 8–39% (6)	37%; 20–56% (11)	41%; 25–63% (13)
Liver fibrosis (0–4)	0	1	2	3, 4
	13.3%; 4–31% (4)	73.3%; 54–88% (22)	13.3%; 4–31% (4)	0% (0)

NAS: non-alcoholic fatty liver disease activity score; NASH: non-alcoholic steatohepatitis; data shown as prevalence in the sample, 95% confidence interval (number of patients); P: number of periodontitis patients; G: number of gingivitis patients.